GlassScriptPhysician profile
Han S Lee
NPI 1265747778
$12,889.67
in general payments reported to CMS, 2019-2025
10 companies · $457 in 2025
The $457 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $516 · 2022: $107 · 2023: $82.73 · 2024: $1,041 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549 · Travel and Lodging: $31.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.24 |
| Travel and Lodging | $31.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $7,579.87 | 2019-2020 | |
| Abbvie INC. | $3,702.43 | 2019-2025 | |
| Revance Therapeutics, INC. | $780.81 | 2024-2025 | Daxxify |
| Boston Scientific Corporation | $337.23 | 2019-2025 | Vercise |
| Medtronic, INC. | $232.93 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $142.67 | 2024-2025 | Crexont |
| Ipsen Biopharmaceuticals, INC | $84.16 | 2022-2023 | Dysport |
| Tactile Systems Technology INC | $15.53 | 2020 | |
| W. L. Gore & Associates, INC. | $14.04 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.